Neuroprotective effect of the combination therapy of melatonin and URB447 after neonatal hypoxia-ischemia
Our data suggest that Melatonin + URB447 improved neurodevelopmental outcomes after HI, a beneficial effect extended to grey and white matter after hypoxia-ischemia in neonatal rats.
Authors
- Daniel Alonso‐Alconada (ORCID: https://orcid.org/0000-0002-9874-2947)
- Ana Catalán (ORCID: https://orcid.org/0000-0002-0418-7904)
- Borja Herrero de la Parte (ORCID: https://orcid.org/0000-0001-5988-1795)
- Marc Chillida (ORCID: https://orcid.org/0000-0002-2204-0439)
- Francisco J. Álvarez (ORCID: https://orcid.org/0000-0002-8690-0506)
- Antonia Álvarez
Institutions
- University of the Basque Country (ES)
- King's College London (GB)
- BioCruces Health research Institute (ES)
- Hospital de Cruces (ES)
Publication Details
- Journal
- BMC Complementary Medicine and Therapies
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1186/s12906-025-05021-7
- Primary Topic
- Neonatal and fetal brain pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Euskal Herriko Unibertsitatea
- Agencia Estatal de Investigación
- Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa